Converting Atrial Fibrillation to NSR Pills or Electrical Thrills Peter Holzberger MD.

53
Converting Atrial Fibrillation to NSR Pills or Electrical Thrills Peter Holzberger MD

Transcript of Converting Atrial Fibrillation to NSR Pills or Electrical Thrills Peter Holzberger MD.

Converting Atrial Fibrillation to NSR

Pills or Electrical Thrills

Peter Holzberger MD

www.mediclicks.net

Background

• Atrial fibrillation is the most common sustained arrhythmia

• Affects 2 million Americans• 6% over the age of 65 experience it• Responsible for 15% strokes

– Benjamin E: Epidemiology of Atrial Fibrillation. In Falk RH, Podrid PJ, eds:Atrial Fibrillation: Mechanisms and Management. 2nd Ed, Lippincott-Raven Press, New York 1997, pp.1-22.

Symptoms

• Inappropriate heart rate response

• Irregular rate

• Loss of atrial systolic function

• Thromboembolism

Choices for Immediate Treatment

• Anticoagulation and Rate Control

• Or

• Conversion to NSR

NSR-Pills Or Electrical Thrills

• Pills– Placebo– Single Dose Antiarrhythmic Treatment– Ibutilide

• Electrical Thrills– Traditional External Cardioversion– Double External Cardioversion– Biphasic Cardioversion

Choices

• 40 yr old healthy female with 6 hrs of palpitations. First time ever.

• Found in atrial fib. Rate slowed with IV lopressor, and patient feels much better.

• ED evaluation entirely normal

• Next step is ?

Choices

• A) DC Cardioversion

• B) P.O. Propafenone

• C) Discharge on p.o. lopressor and revaluate next day

• D) Admit for further workup and treatment

Predictors of Conversion to NSR

• Duration of atrial fib– <24 hrs spontaneous conversion in up to 66%

• Underlying cardiac function

• Underlying cardiac disease

• Age

Pills - Placebo

• Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. A randomized, placebo controlled study – 100 patients PAF (<48 hrs)– IV Amiodarone (3 gms) vs. IV Placebo

– Cotter et al,.Eur Heart J Dec 1999; 20(24):1833-42

Placebo

– Cotter et al,.Eur Heart J Dec 1999; 20(24):1833-42

92

64

0102030405060708090

100

24 hrs

IV amiodaroneIV Placebo

Conversion (%)

P=0.0017

Choices

• 45 yr old on Coumadin for recent DVT presents with several day history of palpitations.

• INR has been therapeutic for several months

• Rate is controlled but still feels poorly• Evaluation entirely unremarkable• What next?

Choices

• A) DC Cardioversion

• B) P.O. Propafenone

• C) Discharge on p.o. lopressor and revaluate next day

• D) Admit for further workup and treatment

Pills - Single Dose Rx

– Boriani et al, Pacing Clin Electrophys Nov 1998; Vol.21 Part II, 2470-74

Single Dose

• 417 patients with AF < 8 days• Randomized to

– Placebo– IV Amiodarone 5mg/kg bolus followed by 1.8

gms/24hrs– IV Propafenone– PO Propafenone 600 mg– PO Flecainide 300 mg

– Boriani et al, Pacing Clin Electrophys Nov 1998; Vol.21 Part II, 2470-74

Single Dose

– Boriani et al, Pacing Clin Electrophys Nov 1998; Vol.21 Part II, 2470-2474

0

20

40

60

80

100

SR≤1 hr SR≤3hr SR≤8hr

PlaceboIV AmioIV PropPO PropPO Flec

Choices

• 45 yr old female with several week history of worsening SOB, no palpitations

• Exam reveals, mild CHF, A fib rate 140, Echo EF 35%-global hypo

• What next?

Choices

• A) DC cardioversion

• B) p.o. Propafenone

• C) Discharge on p.o. lopressor and revaluate next day

• D) Admit for further workup and treatment

Anticoagulation Prior to Conversion to NSR

• At least 3 weeks Therapeutic INR >2.0• Unless arrhythmia is less than 48 hours in duration

– Even then heparin has been advocated in high embolic risk patients

• Mitral stenosis, CHF, previous emboli

– Chest. Sixth ACCP Consensus Conference on Antithrombotic Therapy Vol. 119(1) Suppl. Jan 2001 194S-206S

www.mediclicks.net

TEE Prior to Conversion to NSR

Thrombus

Pills (sort of) -Ibutilide

Pills (sort of) -Ibutilide

Pills (sort of) -Ibutilide

Ibutilide

– Stambler et al, Circulation October 1996; Vol 94, No 7, 1613-21

Ibutilide

• 266 patients (3 hrs to 45 days)– 133 with atrial flutter– 133 with atrial fibrillation

• Randomized to– Placebo/Placebo– 1mg/0.5mg– 1mg/1mg

– Stambler et al, Circulation October 1996; Vol 94, No 7,1613-21

Ibutilide

– Stambler et al, Circulation October 1996; Vol 94, No 7,1613-21

Ibutilide

• Proarrhythmia– PMVT developed in 8.3%

• Sustained PMVT 1.7%

– MMVT developed in 4%

• QTc prolonged an average of 63 msec.• No hemodynamic effects

– Stambler et al, Circulation October 1996; Vol 94, No 7,1613-21

Ibutilide

• Contraindications– Hx of Torsades– QTc > 440– K< 4.0 mEq/L– Concomitant Type 1 or III drug– HR <60– Severe LV dysfunction (EF < 30%)

Ibutilide

• Key Points– Close monitoring during infusion

• For NSR, PMVT (3 beats), QTc >600msec, conduction or hemodynamic problems

– Monitor post infusion for at least 4 hours or until QTc returns to baseline

– (longer with hepatic dysfunction)

– Trained personnel, defibrillator, Code Cart and IV magnesium should be present

Pills Or Electrical Thrills

• Pills– Placebo– Single Dose Antiarrhythmic Treatment– Ibutilide

• Electrical Thrills– Traditional External Cardioversion– Double External Cardioversion– Biphasic Cardioversion

Electrical Thrills - DC

• Used for conversion of atrial fib by Dr Bernard Lown in the 1960’s – 94% of 456 cases of atrial fib

• Overall efficacy felt to be about 85%

• Use of high energy (360J) associated with skin burns and possible myocardial stunning

DC Cardioversion

• Efficacy dependent on– Paddle size and position– Transthoracic impedance– Energy Waveform– Underlying disease

Paddle Position

• Anterior/Posterior #1

Paddle Position

• Anterior/Posterior #2

Paddle Position

• Anterior/Anterior

Transthoracic Impedance

• Lowered by putting pressure on the anterior paddle during cardioversion

Electrical Thrills - Double DC

– Saliba et al, J Am Coll Cardiol 1999; Vol.34, No 7: 2031-34

Double External Cardioversion

• Double Shock

Double External Cardioversion

• 55 patients who had all failed conventional DC cardioversion

• 84% success rate– 9 patients received more than one 720J

• No complications

• Saliba et al, J Am Coll Cardiol 1999; Vol.34, No 7: 2031-34

Pills and Electrical Thrills

– Oral et al, NEJM 1999, Vol. 340 No24:1849-54

Ibutilide and DC Cardioversion

• 100 consecutive patients – 50 assigned conventional DC

– 50 pretreated with 1 mg Ibutilide

– Oral et al, NEJM 1999, Vol. 340 No24:1849-54

72

100

0102030405060708090

100

% Success

DC only

Ibutilide/DC

P<0.001

Ibutilide and DC Cardioversion

• 20% treated with Ibutilide converted without DC

• 14 patients who did not convert with DC alone were then pretreated with Ibutilide– None converted with drug alone– All converted with DC

• Oral et al, NEJM 1999, Vol. 340 No24:1849-54

Electrical Thrills

Damped Biphasic

Biphasic - AF

• 165 patients randomized to monophasic vs. biphasic shocks– Stepped approach

• Biphasic: 70,120,150,170• Monophasic:100,200,300,360

– Mittal et al, Circulation March 2000,Vol.101(11): 1282-87

Biphasic - AF

– Mittal et al, Circulation March 2000,Vol.101(11): 1282-87

Conclusion

• Prior to conversion:– A fib less than 48 hrs or,– Anticoagulation with an INR >2.0 for 3 weeks,

or– TEE showing no clot at time of conversion

• Pills work about 40% of the time• Electrical Thrills work about 90% of the

time

Conclusion

• Biphasic waveform is superior and desirable

• Ibutilide will have a role– unable to perform anesthesia– very effective for atrial flutter– facilitate DC cardioversion

www.mediclicks.net